Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Potential role for anti-angiogenic therapy in abdominal aortic aneurysms.

Vijaynagar B, Bown MJ, Sayers RD, Choke E.

Eur J Clin Invest. 2013 Jul;43(7):758-65. doi: 10.1111/eci.12103. Epub 2013 May 14. Review.

PMID:
23672465
[PubMed - indexed for MEDLINE]
2.

The influence of statins on the expansion rate and rupture risk of abdominal aortic aneurysms.

VAN KUIJK JP, FLU WJ, WITTEVEEN OP, VOUTE M, BAX JJ, POLDERMANS D.

J Cardiovasc Surg (Torino). 2009 Oct;50(5):599-609. Review.

PMID:
19741575
[PubMed - indexed for MEDLINE]
3.

Medical management of small abdominal aortic aneurysms.

Baxter BT, Terrin MC, Dalman RL.

Circulation. 2008 Apr 8;117(14):1883-9. doi: 10.1161/CIRCULATIONAHA.107.735274. Review.

PMID:
18391122
[PubMed - indexed for MEDLINE]
Free Article
4.

Mast cells in abdominal aortic aneurysms.

Shi GP, Lindholt JS.

Curr Vasc Pharmacol. 2013 May;11(3):314-26. Review.

PMID:
22724485
[PubMed - indexed for MEDLINE]
5.

Endovascular repair of abdominal aortic aneurysm: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2002;2(1):1-46. Epub 2002 Mar 1.

PMID:
23074438
[PubMed]
Free PMC Article
6.

Pharmacotherapy of abdominal aortic aneurysms.

Dawson J, Choke E, Sayed S, Cockerill G, Loftus I, Thompson MM.

Curr Vasc Pharmacol. 2006 Apr;4(2):129-49. Review.

PMID:
16611155
[PubMed - indexed for MEDLINE]
7.

Therapeutic potential of tetracycline derivatives to suppress the growth of abdominal aortic aneurysms.

Thompson RW, Liao S, Curci JA.

Adv Dent Res. 1998 Nov;12(2):159-65. Review.

PMID:
9972142
[PubMed - indexed for MEDLINE]
8.

Pharmacological targets in the treatment of abdominal aortic aneurysms.

Bergoeing MP, Thompson RW, Curci JA.

Expert Opin Ther Targets. 2006 Aug;10(4):547-59. Review.

PMID:
16848691
[PubMed - indexed for MEDLINE]
9.

MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.

Thompson RW, Baxter BT.

Ann N Y Acad Sci. 1999 Jun 30;878:159-78.

PMID:
10415728
[PubMed - indexed for MEDLINE]
10.

Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm.

Kaneko H, Anzai T, Takahashi T, Kohno T, Shimoda M, Sasaki A, Shimizu H, Nagai T, Maekawa Y, Yoshimura K, Aoki H, Yoshikawa T, Okada Y, Yozu R, Ogawa S, Fukuda K.

Cardiovasc Res. 2011 Jul 15;91(2):358-67. doi: 10.1093/cvr/cvr080. Epub 2011 Mar 24.

PMID:
21436157
[PubMed - indexed for MEDLINE]
Free Article
11.

Ultrasound screening for abdominal aortic aneurysm: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(2):1-67. Epub 2006 Jan 1.

PMID:
23074490
[PubMed]
Free PMC Article
12.

The pathophysiology of abdominal aortic aneurysm growth: corresponding and discordant inflammatory and proteolytic processes in abdominal aortic and popliteal artery aneurysms.

Abdul-Hussien H, Hanemaaijer R, Kleemann R, Verhaaren BF, van Bockel JH, Lindeman JH.

J Vasc Surg. 2010 Jun;51(6):1479-87. doi: 10.1016/j.jvs.2010.01.057.

PMID:
20488324
[PubMed - indexed for MEDLINE]
Free Article
13.

Rapamycin suppresses experimental aortic aneurysm growth.

Lawrence DM, Singh RS, Franklin DP, Carey DJ, Elmore JR.

J Vasc Surg. 2004 Aug;40(2):334-8.

PMID:
15297830
[PubMed - indexed for MEDLINE]
Free Article
14.

Screening aortic drug treatments through arterial compliance measurements.

Rentschler ME, Baxter BT.

Curr Vasc Pharmacol. 2008 Oct;6(4):250-7. Review.

PMID:
18855713
[PubMed - indexed for MEDLINE]
15.

An animal model of abdominal aortic aneurysm created with peritoneal patch: technique and initial results.

Maynar M, Qian Z, Hernandez J, Sun F, DeMiguel C, Crisostomo V, Usón J, Pineda LF, Espinoza CG, Castañeda WR.

Cardiovasc Intervent Radiol. 2003 Mar-Apr;26(2):168-76. Epub 2003 Mar 6. Review.

PMID:
12616417
[PubMed - indexed for MEDLINE]
16.

Filling of the aneurysmal sac with DEAC-glucosamine in an animal model of abdominal aortic aneurysm following stent-graft repair.

Uflacker R, Brothers T.

J Cardiovasc Surg (Torino). 2006 Aug;47(4):425-36.

PMID:
16953162
[PubMed - indexed for MEDLINE]
17.

Doxycycline does not influence established abdominal aortic aneurysms in angiotensin II-infused mice.

Xie X, Lu H, Moorleghen JJ, Howatt DA, Rateri DL, Cassis LA, Daugherty A.

PLoS One. 2012;7(9):e46411. doi: 10.1371/journal.pone.0046411. Epub 2012 Sep 27.

PMID:
23029514
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization.

Kaneko H, Anzai T, Morisawa M, Kohno T, Nagai T, Anzai A, Takahashi T, Shimoda M, Sasaki A, Maekawa Y, Yoshimura K, Aoki H, Tsubota K, Yoshikawa T, Okada Y, Ogawa S, Fukuda K.

Atherosclerosis. 2011 Aug;217(2):350-7. doi: 10.1016/j.atherosclerosis.2011.03.042. Epub 2011 Apr 8.

PMID:
21530968
[PubMed - indexed for MEDLINE]
19.

Fibrinogen-specific antibody induces abdominal aortic aneurysm in mice through complement lectin pathway activation.

Zhou HF, Yan H, Bertram P, Hu Y, Springer LE, Thompson RW, Curci JA, Hourcade DE, Pham CT.

Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):E4335-44. doi: 10.1073/pnas.1315512110. Epub 2013 Oct 28.

PMID:
24167262
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Pharmacological treatment of abdominal aortic aneurysm.

Miyake T, Morishita R.

Cardiovasc Res. 2009 Aug 1;83(3):436-43. doi: 10.1093/cvr/cvp155. Epub 2009 May 19. Review.

PMID:
19454489
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk